WELCOME TO DELIVER - DELIVERY OF ADVANCED THERAPIES FOR DIABETES TRAINING NETWORK
The DELIVER programme is a training network based on DELIVERy of advanced therapies for diabetes. This project has received funding from the European Union’s Horizon 2020 research and innovation programme
Advanced therapies are new medicinal products based on genes or cells and tissue engineering products (biomaterials), sometimes used in combination with medical devices. They herald revolutionary treatments for a number of chronic diseases affecting society, including the focus of the DELIVER programme, Diabetes Mellitus.
As the incidence of insulin-dependent diabetes continues to rise around the world, so does the need for talented, innovative and entrepreneurial industrially-trained researchers. We aim to DELIVER the next cohort of translational research scientists in the field of advanced therapies and enabling medical devices for pancreatic islet transplantation, a cell therapy which is poised to become more widespread for the treatment of insulin-dependent diabetes.
DELIVER is led by Prof. Garry Duffy (Anatomy, School of Medicine, NUIG)
Early Stage Researchers (ESRs)
Our team of Early Stage Researchers are making important discoveries in our area of focus. While everyone is working in their particular PhD projects, our collaborative Research Program means that we are all working towards a common goal. Read on to find out more.
Giulia Lattanzi is an ESR student who comes from Italy, her background is in Biomedical Engineering. Giulia is working on generating immune tolerance for the therapeutic device produced during this project.
DANIEL DOMINGO LOPEZ
Daniel Domingo Lopez is one of DELIVER's ESRs who hails from Spain. His background is in Chemistry. Daniel is working on a biomaterial which will support the survival of transplanted islets.
Lucien Schreiber is a DELIVER ESR. Lucien is from France and carried out his bachelors degree in Biomedical engineering in NUIG, Ireland. Lucien is working on the synthesis of complex proteins which will enable engraftment of implanted devices. Lucien has also developed a bi-directional wireless communication system which could serve as a base for a future implantable system with real-time data and function management to assess the foreign body response.
Eimear Wallace is a DELIVER ESR. Eimear has a background in Science and Regenerative Medicine in NUIG, Ireland. Eimear is working on fabricating a robotic drug delivery device that can be loaded with a novel injectable hydrogel that electrostatically interacts with the protein produced by another DELIVER ESR.
Chuan-En Lu is a ESR with DELIVER. Lu is from Taiwan and has a background in Pharmacy and Biochemical Science and Technology. Lu is working on the interplay between the surface of a delivery device for encapsulated pancreatic islets and the immunological response which is essential for implant survival. Lu is studying a non-invasive tracking method to examine the progress of fibrosis and thus the feasibility of the materials used.
Abiramy Jeyagaran is an ESR with DELIVER. Abi comes from Canada and her background is in Cell and Molecular Biology. Abi's role is to develop a differentiation method to achieve greater differentiation efficiency to obtain a homogenous population of mature beta cells for use in transplantation. She has developed an expression system using a technology that allows control over when essential genes are expressed
ADVANCED THERAPIES FOR TYPE 1 DIABETES
MARIE CURIE INTERNATIONAL TRAINING NETWORK
Thank you for your interest in our research. Get in touch with us for any questions or comments regarding our work and publications.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 812865
Human Biology Building, School of Medicine, NUI, Galway, Galway, Ireland